Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-06-02T18:53:16.298Z Has data issue: false hasContentIssue false

8 - Laboratory Assessment of Liver Function and Injury in Children

from SECTION I - PATHOPHYSIOLOGY OF PEDIATRIC LIVER DISEASE

Published online by Cambridge University Press:  18 December 2009

By
Vicky Lee Ng M.D., F.R.C.P.C.
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Vicky Lee Ng M.D., F.R.C.P.C.
Affiliation:
Assistant Professor, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada; Medical Director, Liver Transplant Program, Staff Physician, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada
Frederick J. Suchy
Affiliation:
Mount Sinai School of Medicine, New York
Ronald J. Sokol
Affiliation:
University of Colorado, Denver
William F. Balistreri
Affiliation:
University of Cincinnati
Get access

Summary

The liver is a multifunctional organ that is involved in a number of critical excretory, synthetic, and metabolic functions. Biochemical assessment of these functions in children is undertaken by utilizing a number of tests performed in clinical laboratories. Many of the most commonly used serum chemistry tests, such as aminotransferase and alkaline phosphatase levels, are often referred to as liver function tests (LFTs), which is a misnomer as they do not actually measure or indicate liver function. Rather, these tests should be referred to as liver enzyme tests, with the term LFTs reserved to refer to measures of hepatocyte synthetic function such as serum albumin and prothrombin time (PT). Any single biochemical test provides limited information, which must be placed in the context of the entire clinical and historic picture. Currently available laboratory evaluative tests of the liver are used to (1) screen for and document liver injury; (2) identify the type or pattern of liver disorder and the site of injury; (3) prognosticate and follow up children with chronic liver disease; and (4) serially monitor the course of liver disease, evaluate the response to treatment, and adjust a treatment regimen when appropriate.

The widespread availability and frequent use of serum chemistry tests in children have resulted in an increase in the number of both normal and abnormal liver chemistry test values that must be evaluated by physicians. However, some limitations of liver biochemical tests must be recognized [1].

Type
Chapter
Information
Liver Disease in Children , pp. 163 - 176
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Green, R M, Flamm, S. American Gastroenterological Association technical review on the evaluation of liver chemistry tests. Gastroenterology 2002;123:1367–84.CrossRefGoogle Scholar
Kim, H C, Nam, C M, Jee, S H. Normal serum aminotransferase concentration and risk of mortality from liver disease: prospective cohort study. BMJ 2004;328:983.Google ScholarPubMed
Giannini, E G, Testa, R, Savarino, V. Liver enzyme alteration: a guide for clinicians. Can Med Assoc Journal 2005;172:367–79.CrossRefGoogle ScholarPubMed
Adams, P C, Arthur, M J, Boyer, T D. Screening in liver disease: report of an AASLD clinical workshop. Hepatology 2004;39:1204–12.CrossRefGoogle ScholarPubMed
Clark, J M, Brancati, F L, Diehl, A M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960–7.CrossRefGoogle ScholarPubMed
Prati, D, Taioli, E, Zanella, A. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1–9.CrossRefGoogle ScholarPubMed
Kaplan, M M. Alanine transferase levels: what's normal. Ann Intern Med 2002;137:49–50.CrossRefGoogle ScholarPubMed
Kohli, R, Harris, D C, Whitington, P F. Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy. J Pediatr Gastroenterol Nutr 2005;41:121–4.CrossRefGoogle ScholarPubMed
Morse, R P, Rosman, N P. Diagnosis of occult muscular dystrophy: importance of the “chance” finding of elevated serum aminotransferase activities. J Pediatr 1993;122:254–6.CrossRefGoogle ScholarPubMed
Triester, S L, Douglas, D D. Development of macro-aspartate aminotransferase in a patient undergoing specific allergen injection immunotherapy. Am J Gastroenterol 2005;100:243–5.CrossRefGoogle Scholar
Wiltshire, E J, Crooke, M, Grimwood, K. Macro-AST: a benign cause of persistently elevated aspartate aminotransferase. J Pediatr Child Health 2004;40:642–3.CrossRefGoogle ScholarPubMed
Giannini, E, Risso, D, Botta, F. Validity and clinical utility of the aspartate aminotransferase–alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis c virus – related chronic liver disease. Arch Intern Med 2003;163:218–24.CrossRefGoogle ScholarPubMed
Diehl, A M, Potter, J, Boitnott, J. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632–6.Google ScholarPubMed
Rosenthal, P, Haight, M. Aminotransferase as a prognostic index in infants with liver disease. Clin Chem 1990;36:346–8.Google ScholarPubMed
Berman, D H, Leventhal, R I, Gavaler, J S. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100:1129.CrossRefGoogle ScholarPubMed
Farre, C, Esteve, M, Curcoy, A. Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue. Am J Gastroenterol 2002;97:3176–81.CrossRefGoogle ScholarPubMed
Iorio, R, Sepe, A, Giannattasio, A. Hypertransaminasemia in childhood as a marker of genetic liver disorders. J Gastroenterol 2005;40:820–6.CrossRefGoogle ScholarPubMed
Mager, D R, Roberts, E A. Nonalcoholic fatty liver disease in children. Clin Liver Dis 2006;10:109–31.CrossRefGoogle ScholarPubMed
Iannou, G N, Weiss, N S, Boyko, E J. Contribution of metabolic factors to alanine aminotransferase activity in person with other causes of liver disease. Gastroenterology 2005;128:627–35.CrossRefGoogle Scholar
Tiao, G, Ryckman, F C. Pediatric liver transplantation. Clin Liver Dis 2006;10:169–97.CrossRefGoogle ScholarPubMed
Keller, M S, Coln, C E, Trimble, J A. The utility of routine trauma laboratories in pediatric trauma resuscitations. Am J Surg 2004;188:671–8.CrossRefGoogle ScholarPubMed
Kaplowitz, N. Drug-induced liver injury. Clin Infect Dis 2004;38(suppl 2):S44–8.CrossRefGoogle ScholarPubMed
Russo, M W, Watkins, P B. Are patients with elevated liver tests at increased risk of drug-induced liver injury?Gastroenterology 2004;126:1477–80.CrossRefGoogle ScholarPubMed
Chopra, S, Griffin, P H. Laboratory tests and diagnostic procedures in evaluation of liver disease. Am J Med 1985;79:221–30.CrossRefGoogle ScholarPubMed
Kaplan, M M. Alkaline phosphatase. Gastroenterology 1972;62:452–68.Google ScholarPubMed
Clarke, L C, Beck, E. Plasma “alkaline” phosphatase activity. I. Normative data for growing children. J Pediatr 1950;36:335–41.CrossRefGoogle Scholar
Salz, J L, Daum, F, Cohen, M I. Serum alkaline phosphatase activity during adolescence. J Pediatr 1973;82:536–7.CrossRefGoogle ScholarPubMed
Seetharam, S, Sussman, N L, Komoda, T, Alpers, D H. The mechanism of elevated alkaline phosphatase activity after bile duct ligation in the rat. Hepatology 1986;6:374.CrossRefGoogle ScholarPubMed
Crofton, P M. Biochemistry of alkaline phosphatase isoenzymes. CRC Crit Rev Clin Lab Sci 1982;16:161–94.CrossRefGoogle ScholarPubMed
Posen, S, Lee, C, Vines, R. Transient hyperphosphatasemia of infancy – an insufficiently recognized syndrome. Clin Chem 1977;23(2 pt 1):292–4.Google Scholar
Kraut, J R, Metrick, M, Maxwell, N R, Kaplan, M M. Isoenzyme studies in transient hyperphosphatasemia of infancy: ten new cases and a review of the literature. Am J Dis Child 1985;139:736–40.CrossRefGoogle Scholar
Warnes, T W, Hine, P, Kay, G. Intestinal alkaline phosphatase in the diagnosis of liver disease. Gut 1977;18:274–80.CrossRefGoogle Scholar
Bamford, K F, Harris, H, Luffman, J E. Serum alkaline phosphatase and the ABO blood groups. Lancet 1965;1:530–1.CrossRefGoogle ScholarPubMed
McEvoy, M, Skrabanek, P, Wright, E. Family with raised alkaline phosphatase activity in the absence of disease. BMJ 1981; 282:1272–5.CrossRefGoogle ScholarPubMed
Cabrera-Abreu, J C, Green, A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem 2002;39:22–5.CrossRefGoogle ScholarPubMed
Huang, Y C, Chen, H L, Tsai, K S. Serum gamma-glutamyl transpeptidase activity and bile acids in normal Taiwanese infants. Acta Paediatr Taiwan 2002;43:245–8.Google ScholarPubMed
Reference values and SI unit information. Toronto, ON: Hospital for Sick Children, 1993.
Deutsch, J, Fritsch, G, Golles, J, Semmelrock, H J. Effects of anticonvulsive drugs on the activity of gamma-glutamyltransferase and aminotransferases in serum. J Pediatr Gastroenterol Nutr 1986;5:542–8.CrossRefGoogle ScholarPubMed
Maggiore, G, Bernard, O, Hadchouel, M. Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr 1991;12:21–6.CrossRefGoogle ScholarPubMed
Jansen, P L, Sturm, E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003;23:315–22.CrossRefGoogle ScholarPubMed
Carlton, V E, Pawlikowska, L, Bull, L N. Molecular basis of intrahepatic cholestasis. Ann Med 2004;36:606–17.CrossRefGoogle ScholarPubMed
Maggiore, G, Bernard, O, Riely, C A. Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestatis with poor prognosis. J Pediatr 1987;111: 251–2.CrossRefGoogle Scholar
Lachaux, A, Loras-Duclaux, I, Bouvier, R. Benign recurrent cholestasis with normal gamma-glutamyl-transpeptidase activity. J Pediatr. 1992;121:78–80.CrossRefGoogle ScholarPubMed
Ooteghem, N A, Klomp, L W, Berge-Henegouwen, G P, Houwen, R H. Benign recurrent intrahepatic cholestasis progressing to progressive intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol 2002;36:439–43.CrossRefGoogle ScholarPubMed
Combes, B, Shore, G M, Cunningham, F G. Serum gamma-glutamyl transpeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills. Gastroenterology 1977;72:271–4.Google ScholarPubMed
Hill, P G, Sammons, H G. An assessment of 5′-nucleotidase as a liver-function test. Q J Med 1967;36:457–68.Google ScholarPubMed
Ahn, H, Li, C S, Wang, W. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer 2005;45:184–90.CrossRefGoogle ScholarPubMed
Rutenburg, A M, Pineda, E P, Goldberg, J A. Serum leucine aminopeptidase activity: in normal infants, in biliary atresia and in other diseases. Am J Dis Child 1962;103:47–54.CrossRefGoogle ScholarPubMed
Banks, B M, Pineda, E P, Goldberg, J A, Rutenburg, A M. Clinical value of serum leucine aminopeptidase determinations. N Engl J Med 1960;263:1277–81.CrossRefGoogle ScholarPubMed
Doumas, B T, Peters, T. Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 1997;258:3–20.CrossRefGoogle ScholarPubMed
Amitrano, L, Guardascione, M A, Brancaccio, V, Balzano, A. Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83–96.CrossRefGoogle ScholarPubMed
Kaul, V V, Munoz, S J. Coagulopathy of liver disease. Curr Treat Options Gastroenterol 2002;3:433–8.CrossRefGoogle Scholar
Segal, J B, Dzik, W H. Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005;45:1413–25.Google Scholar
Kujovich, J L. Hemostatic defects in end stage liver disease. Crit Care Clin 2005;21:563–87.CrossRefGoogle ScholarPubMed
Croffie, J M, Gupta, S K, Chong, S K, Fitzgerald, J F. Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 1999;103:675–8.CrossRefGoogle ScholarPubMed
Andrew, M, Paes, B, Johnston, M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95–104.CrossRefGoogle ScholarPubMed
Andrew, M, Paes, B, Milner, R. The development of the human coagulation system in the fullterm infant. Blood 1987;72:165–72.Google Scholar
Andrew, M, Paes, B, Milner, R. Development of the coagulation system in the healthy preterm infant. Blood 1988;72:1651–7.Google Scholar
Dixon, J L, Ginsberg, H N. Hepatic synthesis of lipoproteins and apolipoproteins. Semin Liver Dis 1992;12:364–72.CrossRefGoogle ScholarPubMed
Miller, J P. Dyslipoproteinemia of liver disease. Baillieres Clin Endocrinol Metab 1990;4:807–32.CrossRefGoogle ScholarPubMed
Sabesin, S M. Cholestatic lipoproteins: their pathogenesis and significance. Gastroenterology 1982;83:704–9.Google ScholarPubMed
Habib, A, Anastasios, A M, Abou-Assi, S G. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhosis. Gastroenterol Hepatol 2005; 3:286–91.Google Scholar
Malatack, J J, Schald, D J, Urbach, A H. Choosing a pediatric recipient of orthotopic liver transplantation. J Pediatr 1987; 111:479–89.CrossRefGoogle ScholarPubMed
Seidel, D. Lipoproteins in liver diseases. J Clin Chem Clin Biochem 1987;25:541–51.Google Scholar
Lontie, J F, Dubois, D Y, Malmendier, C L. Plasma lipids and apolipoproteins in end-stage liver disease. Clin Chim Acta 1990;195:91–4.CrossRefGoogle ScholarPubMed
Bojanovski, M, Lukermann, R, Schulz-Falten, J. Parameters of lipoprotein metabolism and cholestasis in healthy and cholestatic infants and children. Prog Lipid Res 1991;30:295–300.CrossRefGoogle ScholarPubMed
Trauner, M, Wagner, M, Fickert, P, Zollner, G. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 2005;39(4 suppl 2):S111–24.CrossRefGoogle Scholar
Weiss, J S, Gautam, A, Lauff, J J. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983;309:147–50.CrossRefGoogle ScholarPubMed
Bergh, A A H, Muller, P. Uber eine direkte und eine indirekte Diazoreaktion auf Bilirubin. Biochem Z 1916;77:90–103.Google Scholar
Turkey, R H, Strassburg, C P. Human UDP-glucuronosyltrans-ferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000;40:581–616.Google Scholar
Moyer, V, Freese, D K, Whitington, P F. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004;39:115–28.CrossRefGoogle Scholar
Ferraris, R, Colombatti, G, Forentini, M T. Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary disease: sensitivity, specificity, and predictive value. Dig Dis Sci 1983;28:129–36.CrossRefGoogle Scholar
Festi, D, Morselli Labate, A M, Roda, A. Diagnostic effectiveness of serum bile acids in liver diseases as evaluated by multivariate statistical methods. Hepatology 1983;3:707–13.CrossRefGoogle ScholarPubMed
Mannes, G A, Stellaard, F, Paumgartner, G. Increased serum bile acids in cirrhosis with normal transaminases. Digestion 1982;25: 217–21.CrossRefGoogle ScholarPubMed
Mannes, G A, Thieme, C, Stellaard, F. Prognostic significance of serum bile acids in cirrhosis. Hepatology 1986;6:50–3.CrossRefGoogle ScholarPubMed
Heubi, J. Serum bile acids as markers of liver disease in childhood. J Pediatr Gastroenterol Nutr 1982;1:457–8.Google ScholarPubMed
Suchy, F J, Balistreri, W F, Heubi, J E. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981;80:1037–41.Google ScholarPubMed
Balistreri, W F. Immaturity of hepatic excretory function and the ontogeny of bile acid metabolism. J Pediatr Gastroenterol Nutr 1983;2(suppl):207–14.CrossRefGoogle Scholar
Javitt, N B, Keating, J P, Grand, R J, Harris, R C. Serum bile acid patterns in neonatal hepatitis and extrahepatic biliary atresia. J Pediatr 1977;90:736–9.CrossRefGoogle ScholarPubMed
Nemeth, A, Samuelason, K, Strandvik, B. Serum bile acids as markers of juvenile liver disease in alpha-1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr 1982;1:469–78.CrossRefGoogle ScholarPubMed
Setchell, K D R, O'Connell, N C. Bile acid synthesis and metabolism. In: Walker, W A, Goulet, O, Kleinman, R E., eds. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management. Vol 2. Philadelphia: BC Decker, 2004:1308–43.Google Scholar
Bove, K E, Heubi, J E, Balistreri, W F, Setchell, K D. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr Dev Pathol 2004;7:315–34.CrossRefGoogle ScholarPubMed
Bachmann, C. Mechanisms of hyperammonemia. Clin Chem Lab Med 2002;40:653–62.CrossRefGoogle ScholarPubMed
Panda, S, Radhakrishnan, K. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure. J Assoc Physicians India 2004;52:746–8.Google ScholarPubMed
Cohn, R M, Roth, K S. Hyperammonemia, bane of the brain. Clin Pediatr (Phila) 2004;43:683–9.CrossRefGoogle Scholar
Hourani, B T, Hamlin, E M, Reynolds, T B. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med 1971;127:1033–6.CrossRefGoogle ScholarPubMed
Burra, P, Masier, A. Dynamic tests to study liver function. Eur Rev Med Pharmacol Sci 2004;8:19–21.Google ScholarPubMed
Orlando, R, Palatini, P. The effect of age on plasma MEGX concentrations. Br J Clin Pharmacol 1997;44:206–8.CrossRefGoogle ScholarPubMed
Tanaka, E, Inomata, S, Yasuhara, H. The clinical importance of conventional and quantitative liver function tests in liver transplantation. J Clin Pharmacol Ther 2000;25:411–19.CrossRefGoogle ScholarPubMed
Lebel, S, Nakamachi, Y, Hemming, A. Glycine conjugation of para-aminobenzoic acid (PABA): a pilot study of a novel prognostic test in acute liver failure in children. J Pediatr Gastroenterol Nutr 2003;36:62–71.CrossRefGoogle ScholarPubMed
Furuya, K N, Durie, P R, Roberts, E A. Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function. Clin Biochem 1995;28:531–40.CrossRefGoogle ScholarPubMed
Weizman, Z, Forstner, G G, Gaskin, K J. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Gastroenterology 1985;89:596–604.CrossRefGoogle ScholarPubMed
Gunawardhana, L, Barr, J, Weir, A J. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture. Drug Metab Dispos 1991;19:648–53.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×